explore -WSS

explore

author：fashion 2025-09-29 01:45:28 - browse：52262

Ula Jurkunas, associate director of the cornea service at Mass Eye and Ear, performs the first CALEC surgery. Courtesy Mass Eye and Ear

The first time Phillip Durst saw the big A on the chart, he could hardly believe it. It was the first in a series of letters to check his vision in his left eye. “They keep flipping the chart and it keeps getting smaller and smaller, and I keep identifying the letters — that was huge,” said Durst. “It’s like a miracle.”

A year earlier, in April 2017, Durst had lost sight from that same eye after it was hit by a caustic water treatment solution in a work accident. The damage was so severe that a standard corneal transplant would not resolve it. But in April 2018, he underwent a new, innovative procedure: An eye stem cell transplant led by Ula Jurkunas, the associate director of the cornea service at Mass Eye and Ear in Boston.

Durst, now 51 years old, is the first of four patients who were included in a Phase 1 trial of Cultivated Autologous Limbal Epithelial Cell (CALEC) transplant, the results of which were published Friday in Science Advances. The procedure allowed him to become a suitable candidate for another surgery, the artificial corneal transplant, while rehabilitating his vision — and his life.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Data don't support strong claims for Covid

WSS

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Sutter Health’s antitrust win overturned by appeals court

BD to buy Edwards patient monitoring unit for $4.2 billion

Structure Therapeutics oral GLP

Elevance PBM president out as customers face prescription chaos

White House touts steps to stem shortages of cancer treatments

Wikipedia

explore

explore

Hepatitis C has a cure — but many Americans still lack access to it

Generate Biomedicines machine learning biotech raises $273M

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Generate Biomedicines machine learning biotech raises $273M

Medicare details structure of new drug price negotiation program

How CO2 helps viruses stay alive longer in the air

The high cost of giving birth even with insurance

For pregnant people, addiction treatment shouldn't mean a call to child protective services

DIEP, the 'gold standard' of breast reconstruction, is under threat

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

hotspot

Illumina board agrees to spin off Grail, as divestment plans proceed

How to make the FDA’s new prescription one

Regeneron agrees to White House price limits on anti

Stopping antidepressants leads to symptoms for 1 in 6 patients

Generate Biomedicines machine learning biotech raises $273M

Finland to offer bird flu vaccine to select groups of people, a possible global first

entertainment

knowledge

leisure time

hotspot